Free Trial
NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

Pediatrix Medical Group logo
$14.46 -0.22 (-1.46%)
Closing price 01/28/2025 03:59 PM Eastern
Extended Trading
$14.46 0.00 (-0.03%)
As of 01/28/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Pediatrix Medical Group Stock (NYSE:MD)

Key Stats

Today's Range
$14.38
$14.62
50-Day Range
$12.46
$15.01
52-Week Range
$6.62
$16.41
Volume
435,069 shs
Average Volume
504,310 shs
Market Capitalization
$1.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25
Consensus Rating
Hold

Company Overview

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Pediatrix Medical Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
63rd Percentile Overall Score

MD MarketRank™: 

Pediatrix Medical Group scored higher than 63% of companies evaluated by MarketBeat, and ranked 437th out of 951 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pediatrix Medical Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Pediatrix Medical Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Pediatrix Medical Group are expected to grow by 9.52% in the coming year, from $1.26 to $1.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pediatrix Medical Group is -4.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pediatrix Medical Group is -4.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Pediatrix Medical Group has a PEG Ratio of 1.42. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Pediatrix Medical Group has a P/B Ratio of 1.43. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pediatrix Medical Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.74% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently increased by 0.87%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pediatrix Medical Group does not currently pay a dividend.

  • Dividend Growth

    Pediatrix Medical Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.74% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently increased by 0.87%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pediatrix Medical Group has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.81 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Pediatrix Medical Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 3 people have searched for MD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pediatrix Medical Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $553,388.00 in company stock.

  • Percentage Held by Insiders

    Only 2.00% of the stock of Pediatrix Medical Group is held by insiders.

  • Percentage Held by Institutions

    97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pediatrix Medical Group's insider trading history.
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

MD Stock News Headlines

Pediatrix Medical Group (NYSE:MD) Raised to Buy at StockNews.com
A deadly mistake in my prediction…
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Former Pediatrix CEO returns as leader after 2 years
Mark Ordan returns as Pediatrix CEO, shares surge
See More Headlines

MD Stock Analysis - Frequently Asked Questions

Pediatrix Medical Group's stock was trading at $13.12 at the start of the year. Since then, MD stock has increased by 10.3% and is now trading at $14.4650.
View the best growth stocks for 2025 here
.

Pediatrix Medical Group, Inc. (NYSE:MD) announced its quarterly earnings results on Friday, November, 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The firm's quarterly revenue was up .9% compared to the same quarter last year.

Pediatrix Medical Group's top institutional shareholders include Pacer Advisors Inc. (3.15%), Empowered Funds LLC (0.33%), Nordea Investment Management AB (0.31%) and Harbor Capital Advisors Inc. (0.06%). Insiders that own company stock include C Marc Richards, James D Swift, Mark S Ordan, Mary Ann E Moore, Laura A Linynsky and Shirley A Weis.
View institutional ownership trends
.

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
11/01/2024
Today
1/28/2025
Next Earnings (Estimated)
2/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Services
CUSIP
58502B10
Employees
5,170
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$16.25
High Stock Price Target
$18.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+12.3%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-60,410,000.00
Pretax Margin
-13.63%

Debt

Sales & Book Value

Annual Sales
$1.99 billion
Cash Flow
$1.61 per share
Book Value
$10.10 per share

Miscellaneous

Free Float
84,162,000
Market Cap
$1.24 billion
Optionable
Optionable
Beta
1.58

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NYSE:MD) was last updated on 1/29/2025 by MarketBeat.com Staff
From Our Partners